SummaryTarget controlled infusions of propofol use a pharmacokinetic ⁄ pharmacodynamic model to calculate an effect site concentration of the drug. We assessed the cardiovascular stability of 10 healthy patients using non-invasive thoracic bioimpedance and their 'depth' of anaesthesia using the Bispectral index after they had been anaesthetised to a constant effect site concentration of propofol (6.5 min from starting). Each patient had no surgical stimulus and received no intravenous fluid during the study period. The patients also received effect site target controlled remifentanil (steady state 2.5 min from starting) and a bolus of vecuronium to facilitate intubation and ventilation. We mathematically calculated when each measured parameter would reach a state of stability (i.e. with 95% certainty). Heart rate levelled off at 20 min, Bispectral index at 32 min, and cardiac index and mean arterial pressure at 47 min after achieving effect site stability, the final levels being, respectively, 21%, 47%, 14% and 28% lower than those at effect site stability. We conclude that cardiovascular parameters continue to change to a clinically significant degree after achieving a constant effect site concentration of propofol via target controlled infusions. Intravenous anaesthesia using a propofol infusion is a widely used anaesthetic technique. In particular, the use of a target controlled infusion (TCI) system has been validated to predict plasma concentrations of propofol accurately [1] There is a good correlation between the predicted effect site concentration and depth of anaesthesia as recorded by various monitors (auditory evoked potentials (AEP), Bispectral index (BIS) and entropy [2,3]). Considering its established clinical use, there are sparse published data, from small numbers of patients, on the haemodynamic effects of propofol on healthy individuals [4,5]. The cardiovascular effects observed under propofol anaesthesia are a maintained stroke volume, slightly reduced cardiac index, reduced systemic vascular resistance, reduced heart rate, and reduced mean arterial pressure [6]. However, the temporal relationship between effect size and the occurrence of the cardiovascular effects and depth of anaesthesia is unclear. A previous study by Kazama et al. [7] showed that, using the Gepts model of propofol pharmacokinetics, the maximal cardiovascular depression (using systolic blood pressure only) would happen 8 min after peak plasma concentrations of propofol.Ethically, it is difficult to study the effects of drugs on cardiovascular parameters in healthy individuals using invasive monitoring. Transthoracic electrical bioimpedance estimates cardiac output by measuring non-invasive changes in the resistance to a small current applied across the patient's thorax over time during the cardiac cycle. This method has been validated against conventional thermodilution via pulmonary artery catheterisation with a correlation coefficient of 0.95 and a concordance of 0.99 [8]. This non-invasive method may also be more ethical...